Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Autolus Therapeutics and Noile-Immune Announce Licensing Agreement
Thursday, November 14, 2019Autolus Therapeutics plc a clinicalstage biopharmaceutical company developing nextgeneration programmed T cell therapies and NoileImmune Biotech Inc Tokyo Japan a biotechnology company focusing on the development of innovative cancer immunotherapies...
Gossamer Bio Announces Clinical Trial Collaboration Agreement With Merck
Wednesday, November 13, 2019Gossamer Bio Inc a clinicalstage biopharmaceutical company today announced that it has entered into a clinical collaboration agreement with Merck known as MSD outside the US and Canada to evaluate the combination of Gossamers investigational product...
LEO Pharma Exercises Option with HitGen to License Compounds for Development of Novel Class of Drugs in Dermatology
Wednesday, November 13, 2019LEO Pharma AS and HitGen Inc are pleased to announce that HitGen and LEO Pharma expands their collaboration with a license to develop a novel class of drugs for a dermatology indication
UroGen Pharma Announces Exclusive License Agreement with Agenus Inc to Advance Treatment of Urinary Tract Cancers
Tuesday, November 12, 2019UroGen Pharma Ltd a clinicalstage biopharmaceutical company developing treatments to address unmet needs in the field of urooncology today announced that it has entered into an exclusive worldwide license agreement with Agenus Inc to develop and comm...
Galectin Therapeutics Reaches Agreement with Siemens Healthineers to Collaborate on NASH and Liver Fibrosis
Tuesday, November 12, 2019Galectin Therapeutics Inc the leading developer of therapeutics that target galectin proteins announced a collaboration agreement with Siemens Healthineers a global leader in medical technology in nonalcoholic steatohepatitis NASH and liver fibrosis...
F2G Receives US FDA Breakthrough Therapy Designation for Olorofim
Monday, November 11, 2019FG Ltd a UK and Austriabased biotech company developing novel therapies for lifethreatening systemic fungal infections announced today that the US Food and Drug Administration FDA has granted Breakthrough Therapy designation to its lead firstinclass...
SQZ Biotech and AskBio Announce Research Collaboration to Create Immune Tolerization Products for AAV Gene Therapies
Friday, November 08, 2019SQZ Biotechnologies SQZ and Asklepios BioPharmaceutical Inc AskBio announced a research collaboration to create tolerizing antigen carriers TACs containing AAV adenoassociated virus components to solve one of gene therapys biggest challenges the bar...
AvantGen Enters a Strategic Collaboration Agreement to Develop Novel Anti-Cancer Therapeutic With Its NK Cell Engager Technology
Friday, November 08, 2019AvantGen Inc a biotechnology company with its array of technology platforms for antibody discovery optimization and novel NK cell engager generation today announced a strategic collaboration with an undisclosed biopharmaceutical company for the purpo...
Amneal Enters into a Licensing Agreement with Kashiv BioSciences, LLC to Develop and Commercialize K127 for the Treatment of Myasthenia Gravis
Thursday, November 07, 2019Amneal Pharmaceuticals Inc today announced that it has entered into a licensing agreement with Kashiv BioSciences LLC for the development and commercialization of Kashivs orphan drug K pyridostigmine for the treatment of Myasthenia Gravis Through thi...
Artios Pharma, MD Anderson and ShangPharma Announce In-Licensing Agreement for DNA Damage Response Inhibitor
Thursday, November 07, 2019Artios Pharma Limited Artios The University of Texas MD Anderson Cancer Center MD Anderson and ShangPharma Innovation ShangPharma today announce the inlicensing by Artios of a smallmolecule ATR inhibitor programme developed jointly by MD Anderson and...
